160 related articles for article (PubMed ID: 21883535)
1. Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population.
Handberg A; Højlund K; Gastaldelli A; Flyvbjerg A; Dekker JM; Petrie J; Piatti P; Beck-Nielsen H;
J Intern Med; 2012 Mar; 271(3):294-304. PubMed ID: 21883535
[TBL] [Abstract][Full Text] [Related]
2. Identification of the oxidized low-density lipoprotein scavenger receptor CD36 in plasma: a novel marker of insulin resistance.
Handberg A; Levin K; Højlund K; Beck-Nielsen H
Circulation; 2006 Sep; 114(11):1169-76. PubMed ID: 16952981
[TBL] [Abstract][Full Text] [Related]
3. Circulating soluble CD36 is a novel marker of liver injury in subjects with altered glucose tolerance.
Fernández-Real JM; Handberg A; Ortega F; Højlund K; Vendrell J; Ricart W
J Nutr Biochem; 2009 Jun; 20(6):477-84. PubMed ID: 18789673
[TBL] [Abstract][Full Text] [Related]
4. Soluble CD36 (sCD36) clusters with markers of insulin resistance, and high sCD36 is associated with increased type 2 diabetes risk.
Handberg A; Norberg M; Stenlund H; Hallmans G; Attermann J; Eriksson JW
J Clin Endocrinol Metab; 2010 Apr; 95(4):1939-46. PubMed ID: 20139232
[TBL] [Abstract][Full Text] [Related]
5. Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatment.
Glintborg D; Højlund K; Andersen M; Henriksen JE; Beck-Nielsen H; Handberg A
Diabetes Care; 2008 Feb; 31(2):328-34. PubMed ID: 18000176
[TBL] [Abstract][Full Text] [Related]
6. Soluble CD36- a marker of the (pathophysiological) role of CD36 in the metabolic syndrome?
Koonen DP; Jensen MK; Handberg A
Arch Physiol Biochem; 2011 May; 117(2):57-63. PubMed ID: 21250778
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients.
Liani R; Halvorsen B; Sestili S; Handberg A; Santilli F; Vazzana N; Formoso G; Aukrust P; Davì G
Free Radic Biol Med; 2012 Apr; 52(8):1318-24. PubMed ID: 22343420
[TBL] [Abstract][Full Text] [Related]
8. High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C.
Petta S; Handberg A; Marchesini G; Cammà C; Di Marco V; Cabibi D; Macaluso FS; Craxì A
J Viral Hepat; 2013 Mar; 20(3):174-82. PubMed ID: 23383656
[TBL] [Abstract][Full Text] [Related]
9. Intima-media thickness of the carotid arteries in subjects with hyperinsulinaemia (insulin resistance).
Hidvégi T; Szatmári F; Hetyési K; Bíró L; Jermendy G
Diabetes Nutr Metab; 2003 Jun; 16(3):139-44. PubMed ID: 14635730
[TBL] [Abstract][Full Text] [Related]
10. Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population.
Gastaldelli A; Kozakova M; Højlund K; Flyvbjerg A; Favuzzi A; Mitrakou A; Balkau B;
Hepatology; 2009 May; 49(5):1537-44. PubMed ID: 19291789
[TBL] [Abstract][Full Text] [Related]
11. Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease.
García-Monzón C; Lo Iacono O; Crespo J; Romero-Gómez M; García-Samaniego J; Fernández-Bermejo M; Domínguez-Díez A; Rodríguez de Cía J; Sáez A; Porrero JL; Vargas-Castrillón J; Chávez-Jiménez E; Soto-Fernández S; Díaz A; Gallego-Durán R; Madejón A; Miquilena-Colina ME
Eur J Clin Invest; 2014 Jan; 44(1):65-73. PubMed ID: 24134687
[TBL] [Abstract][Full Text] [Related]
12. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects.
Musso G; Gambino R; Bo S; Uberti B; Biroli G; Pagano G; Cassader M
Diabetes Care; 2008 Mar; 31(3):562-8. PubMed ID: 18056890
[TBL] [Abstract][Full Text] [Related]
13. Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution.
Bozzetto L; Prinster A; Mancini M; Giacco R; De Natale C; Salvatore M; Riccardi G; Rivellese AA; Annuzzi G
Eur J Clin Invest; 2011 Jan; 41(1):39-44. PubMed ID: 20825466
[TBL] [Abstract][Full Text] [Related]
14. Microcirculatory damage of common carotid artery wall in obese and non obese subjects.
Ciccone M; Maiorano A; De Pergola G; Minenna A; Giorgino R; Rizzon P
Clin Hemorheol Microcirc; 1999; 21(3-4):365-74. PubMed ID: 10711772
[TBL] [Abstract][Full Text] [Related]
15. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease.
Targher G; Bertolini L; Padovani R; Rodella S; Zoppini G; Zenari L; Cigolini M; Falezza G; Arcaro G
Diabetes Care; 2006 Jun; 29(6):1325-30. PubMed ID: 16732016
[TBL] [Abstract][Full Text] [Related]
16. Is plasma-soluble CD36 associated with density of atheromatous plaque and ankle-brachial index in early-onset coronary artery disease patients?
Rać M; Krzystolik A; Rać M; Safranow K; Dziedziejko V; Goschorska M; Poncyljusz W; Chlubek D
Kardiol Pol; 2016; 74(6):570-5. PubMed ID: 26620683
[TBL] [Abstract][Full Text] [Related]
17. Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis.
Yeung DC; Xu A; Cheung CW; Wat NM; Yau MH; Fong CH; Chau MT; Lam KS
Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1796-802. PubMed ID: 17510463
[TBL] [Abstract][Full Text] [Related]
18. Glucose turnover and intima media thickness of internal carotid artery in type 2 diabetes offspring.
Anderwald C; Pfeiler G; Nowotny P; Anderwald-Stadler M; Krebs M; Bischof MG; Kozakova M; Luger A; Pacini G; Roden M; Waldhäusl W
Eur J Clin Invest; 2008 Apr; 38(4):227-37. PubMed ID: 18339003
[TBL] [Abstract][Full Text] [Related]
19. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
Hung J; McQuillan BM; Thompson PL; Beilby JP
Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
[TBL] [Abstract][Full Text] [Related]
20. Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls.
Heebøll S; Poulsen MK; Ornstrup MJ; Kjær TN; Pedersen SB; Nielsen S; Grønbæk H; Handberg A
Int J Obes (Lond); 2017 Feb; 41(2):262-267. PubMed ID: 27916988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
